But what's been reported so far is informal. We essentially have stories about 4 patients because so much info is unknown. We are taking causation at Cytodyn's word. Which is fine, as I said before, I believe in the cancer possibilities of leronlimab. But we don't have anything even remotely close to empirical evidence that leronlimab will work for cancer patients.

I'm not a doc or a medical researcher but I do have a geology degree and spent 12 years working as a lab tech in chemistry labs with high standards of quality control.